Expression of a Fas-like proapoptotic molecule on the lymphocytes of Xenopus laevis
Immunology Letters, ISSN: 0165-2478, Vol: 64, Issue: 1, Page: 31-38
1998
- 6Citations
- 2Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations6
- Citation Indexes6
- CrossRef5
- Captures2
- Readers2
Article Description
Ligation of the externally expressed Fas (APO 1 /CD95) molecule will initiate programmed cell death (apoptosis), in many mammalian developing and adult cells. Fas-induced apoptosis has not been demonstrated with the cells of any non-mammalian vertebrate. We immunostained suspensions of splenocytes from adult Xenopus laevis, the South African clawed toad, with a polyclonal rabbit anti-human Fas antibody raised against the amino acid residues 321–335 of human Fas. The binding was specific, as it was dramatically reduced by preincubation of the antibody with the Fas peptide used to make it, but not with a Fas-ligand (FasL) peptide. The binding was enhanced after in vitro exposure of the splenocytes to phytahemagglutinin (PHA), a T cell mitogen and apoptogen in this species. Sections of developing Xenopus larval tissue were also immunostained with the polyclonal rabbit anti-human Fas antibody. Consistant binding of thymocytes and splenocytes was not observed until early metamorphosis in these immunological sites. A monoclonal mouse anti-human Fas antibody, previously used to stimulate apoptosis in mammalian cells, induced significant levels of apoptosis in adult Xenopus splenocytes and additionally, bound specifically to a splenocyte extract, as assayed by ELISA. Thus, a molecule on Xenopus splenocytes shares both structural and functional homologies with human Fas, indicating the evolutionary conservation within vertebrates of this means of initiating apoptosis.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0165247898000789; http://dx.doi.org/10.1016/s0165-2478(98)00078-9; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0032417849&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/9865599; http://linkinghub.elsevier.com/retrieve/pii/S0165247898000789; http://api.elsevier.com/content/article/PII:S0165247898000789?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0165247898000789?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S0165247898000789; http://dx.doi.org/10.1016/s0165-2478%2898%2900078-9; https://dx.doi.org/10.1016/s0165-2478%2898%2900078-9
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know